Featured News

A study from the University of Chicago has demonstrated that B-cells are required for the development of villous atrophy (intestinal damage) in celiac disease. This finding provides support for the exploration of B-cell–directed therapies for the treatment of celiac disease.

Save the date for the University of Chicago Celiac Disease Center’s Annual Celiac Education Day on Saturday, October 21, 2017. Celiac Disease Foundation (CDF) is proud to be a co-sponsor…

It is common for those with celiac disease to turn to over-the-counter (OTC) or prescription loperamide (brand name: Imodium) for short-term treatment of diarrhea. The FDA has recently issued a…